54.75
price up icon0.51%   0.28
pre-market  Pre-market:  55.84   1.09   +1.99%
loading
Bright Minds Biosciences Inc stock is traded at $54.75, with a volume of 124.62K. It is up +0.51% in the last 24 hours and down -9.74% over the past month. Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.
See More
Previous Close:
$54.47
Open:
$54.41
24h Volume:
124.62K
Relative Volume:
1.26
Market Cap:
$385.66M
Revenue:
-
Net Income/Loss:
$-4.98M
P/E Ratio:
-41.55
EPS:
-1.3177
Net Cash Flow:
$-3.85M
1W Performance:
-10.51%
1M Performance:
-9.74%
6M Performance:
+78.34%
1Y Performance:
+16.99%
1-Day Range:
Value
$52.40
$55.52
1-Week Range:
Value
$52.04
$63.67
52-Week Range:
Value
$23.18
$70.23

Bright Minds Biosciences Inc Stock (DRUG) Company Profile

Name
Name
Bright Minds Biosciences Inc
Name
Phone
-
Name
Address
-
Name
Employee
0
Name
Twitter
Name
Next Earnings Date
Name
Latest SEC Filings
Name
DRUG's Discussions on Twitter

Compare DRUG with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
DRUG
Bright Minds Biosciences Inc
54.75 386.12M 0 -4.98M -3.85M -1.3177
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
425.57 107.66B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
651.80 68.74B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
456.04 58.93B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
818.50 50.51B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
189.60 41.29B 447.02M -1.18B -868.57M -6.1812

Bright Minds Biosciences Inc Stock (DRUG) Upgrades & Downgrades

Date Action Analyst Rating Change
Sep-08-25 Initiated BTIG Research Buy
May-13-25 Initiated TD Cowen Buy
May-07-25 Initiated Chardan Capital Markets Buy
Jan-23-25 Initiated Piper Sandler Overweight
Jan-10-25 Initiated Cantor Fitzgerald Overweight
Jan-10-25 Initiated H.C. Wainwright Buy
Nov-26-24 Initiated Robert W. Baird Outperform
View All

Bright Minds Biosciences Inc Stock (DRUG) Latest News

pulisher
02:18 AM

Will Bright Minds Biosciences Inc. stock attract ESG investors2025 Top Decliners & Technical Confirmation Trade Alerts - newser.com

02:18 AM
pulisher
02:16 AM

Building trade automation scripts for Bright Minds Biosciences Inc.Market Growth Review & Consistent Profit Focused Trading Strategies - newser.com

02:16 AM
pulisher
01:53 AM

Is Bright Minds Biosciences Inc. a candidate for recovery play2025 Market Overview & Consistent Income Trade Ideas - newser.com

01:53 AM
pulisher
Nov 02, 2025

Real time breakdown of Bright Minds Biosciences Inc. stock performance2025 Performance Recap & High Accuracy Trade Alerts - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

What’s next for Bright Minds Biosciences Inc. stock priceJuly 2025 Gainers & Technical Entry and Exit Tips - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

A activityEarnings Performance Report & Weekly High Return Stock Opportunities - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Does Bright Minds Biosciences Inc. qualify in momentum factor screeningQuarterly Profit Summary & Real-Time Buy Zone Alerts - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Pattern recognition hints at Bright Minds Biosciences Inc. upsideExit Point & Consistent Return Investment Signals - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

What machine learning models say about Bright Minds Biosciences Inc.Weekly Profit Analysis & Smart Allocation Stock Reports - newser.com

Nov 02, 2025
pulisher
Nov 01, 2025

Identifying reversal signals in Bright Minds Biosciences Inc.2025 Market Outlook & Daily Profit Maximizing Trade Tips - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Is Bright Minds Biosciences Inc. stock a safe investment in uncertain marketsJuly 2025 Snapshot & Reliable Entry Point Trade Alerts - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Using data models to predict Bright Minds Biosciences Inc. stock movementPortfolio Gains Report & Daily Technical Forecast Reports - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Bright Minds Biosciences Inc. stock prediction for this weekWeekly Stock Report & Precise Buy Zone Identification - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Is Bright Minds Biosciences Inc. stock a good choice for value investorsWeekly Stock Recap & Verified Entry Point Signals - newser.com

Nov 01, 2025
pulisher
Oct 31, 2025

Bright Minds Biosciences Inc Stock Analysis and ForecastDividend Stock Watch & Get Trading Help From Experienced Users - earlytimes.in

Oct 31, 2025
pulisher
Oct 31, 2025

Developing predictive dashboards with Bright Minds Biosciences Inc. dataPortfolio Value Report & Daily Technical Stock Forecast Reports - newser.com

Oct 31, 2025
pulisher
Oct 30, 2025

Bright Minds Biosciences Inc. (DRUG) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK

Oct 30, 2025
pulisher
Oct 30, 2025

Bright Minds Biosciences to Present at Upcoming Conferences - The Manila Times

Oct 30, 2025
pulisher
Oct 30, 2025

Bright Minds (NASDAQ: DRUG) to present at Guggenheim, Jefferies; 60-day webcast replay - Stock Titan

Oct 30, 2025
pulisher
Oct 30, 2025

Published on: 2025-10-30 00:39:56 - newser.com

Oct 30, 2025
pulisher
Oct 29, 2025

Bright Minds Biosciences Advances Epilepsy Treatment with BMB-101 Study - TipRanks

Oct 29, 2025
pulisher
Oct 29, 2025

What is Bright Minds Biosciences Inc (DRUG) Price Targets? - fostersleader.com

Oct 29, 2025
pulisher
Oct 29, 2025

Bright Minds Biosciences Inc. (NASDAQ:DRUG) Given Consensus Rating of "Buy" by Brokerages - MarketBeat

Oct 29, 2025

Bright Minds Biosciences Inc Stock (DRUG) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$37.54
price up icon 1.62%
$93.48
price up icon 0.96%
$28.61
price down icon 0.21%
$103.91
price down icon 0.73%
biotechnology ONC
$310.48
price up icon 0.73%
$189.60
price down icon 2.38%
Cap:     |  Volume (24h):